Investigation of the Effectiveness of Surgical Treatment on Maxillary Medication-Related Osteonecrosis of the Jaw: A Literature Review

被引:3
作者
Hsu, Kun-Jung [1 ,2 ]
Hsiao, Szu-Yu [1 ,3 ]
Chen, Ping-Ho [1 ]
Chen, Han-Sheng [4 ]
Chen, Chun-Ming [1 ,5 ]
机构
[1] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung 80708, Taiwan
[2] Kaohsiung Med Univ Hosp, Dept Dent, Kaohsiung 80756, Taiwan
[3] Kaohsiung Med Univ Hosp, Div Dent Child & Special Needs, Kaohsiung 80756, Taiwan
[4] Kaohsiung Municipal Siaogang Hosp, Dept Dent, Kaohsiung 80812, Taiwan
[5] Kaohsiung Med Univ Hosp, Div Oral & Maxillofacial Surg, Dept Dent, Kaohsiung 80756, Taiwan
关键词
MRONJ; BRONJ; maxilla; surgery; recurrence; literature review; BISPHOSPHONATE-RELATED OSTEONECROSIS; ADVERSE DRUG-REACTIONS; POSITION PAPER; MANAGEMENT; RISK; BONE; THERAPY; OSTEOPOROSIS; ASSOCIATION; PREVENTION;
D O I
10.3390/jcm10194480
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Medication-related osteonecrosis of the jaw (MRONJ) occurs after exposure to medication (antiresorptive or antiangiogenic agents) for bone-related complications. It is more common in the mandible than in the maxilla. The present study investigated maxillary MRONJ in elderly patients through a meta-analysis. Methods: Keywords, including "MRONJ ", "maxilla ", and "surgery ", were entered into databases, including Embase, PubMed/MEDLINE, Cochrane Library, and ProQuest, which were searched systematically. Results: Investigating 77 studies, we found that 18 (2 case reports and 16 case series) papers conformed to the standards. The results revealed a 2.6:1 female-to-male ratio of disease occurrence. The average age of patients was 70.6 +/- 5.5 years, and most patients were in the third stage (43.6%). The average time of medication usage was 50.0 +/- 20.1 months. The pooled proportion of clinical efficacy of surgery was 86%. Conclusion: To prevent and manage MRONJ, all elderly patients should maintain proper oral hygiene and receive dental examinations regularly. Risk assessment and safety management of MRONJ should be performed by medical teams.
引用
收藏
页数:16
相关论文
共 49 条
[1]   Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series [J].
Aljohani, Suad ;
Troeltzsch, Matthias ;
Hafner, Sigurd ;
Kaeppler, Gabriele ;
Mast, Gerson ;
Otto, Sven .
ORAL DISEASES, 2019, 25 (02) :497-507
[2]   The Role of Surgical Resection in the Management of Bisphosphonate-Related Osteonecrosis of the Jaws [J].
Carlson, Eric R. ;
Basile, John D. .
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2009, 67 (05) :85-95
[3]   Adverse drug reactions in special populations - the elderly [J].
Davies, E. A. ;
O'Mahony, M. S. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) :796-807
[4]   The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention [J].
Di Fede, Olga ;
Panzarella, Vera ;
Mauceri, Rodolfo ;
Fusco, Vittorio ;
Bedogni, Alberto ;
Lo Muzio, Lorenzo ;
Sipmo Onj, Board ;
Campisi, Giuseppina .
BIOMED RESEARCH INTERNATIONAL, 2018, 2018
[5]   Osteonecrosis of the jaw related to bevacizumab [J].
Estilo, Cherry L. ;
Fornier, Monica ;
Farooki, Azeez ;
Carlson, Diane ;
Bohle, George, III ;
Huryn, Joseph M. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (24) :4037-4038
[6]   Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates [J].
Farrugia, MC ;
Summerlin, DJ ;
Krowiak, E ;
Huntley, T ;
Freeman, S ;
Borrowdale, R ;
Tomich, C .
LARYNGOSCOPE, 2006, 116 (01) :115-120
[7]   Auto-Fluorescence and Histopathologic Evaluation of Medication-Related Osteonecrosis of the Jaws: Perspectives for Treatment [J].
Giovannacci, Ilaria ;
Vescovi, Paolo ;
Magnoni, Cristina ;
Corradi, Domenico ;
Corcione, Luigi ;
Lucchina, Alberta Greco ;
Mortellaro, Carmen ;
Nammour, Samir ;
Meleti, Marco .
JOURNAL OF CRANIOFACIAL SURGERY, 2019, 30 (04) :1039-1043
[8]   Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study [J].
Hasegawa, T. ;
Ueda, N. ;
Yamada, SI. ;
Kato, S. ;
Iwata, E. ;
Hayashida, S. ;
Kojima, Y. ;
Shinohara, M. ;
Tojo, I. ;
Nakahara, H. ;
Yamaguchi, T. ;
Kirita, T. ;
Kurita, H. ;
Shibuya, Y. ;
Soutome, S. ;
Akashi, M. .
OSTEOPOROSIS INTERNATIONAL, 2021, 32 (11) :2323-2333
[9]   A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? [J].
Hasegawa, T. ;
Kawakita, A. ;
Ueda, N. ;
Funahara, R. ;
Tachibana, A. ;
Kobayashi, M. ;
Kondou, E. ;
Takeda, D. ;
Kojima, Y. ;
Sato, S. ;
Yanamoto, S. ;
Komatsubara, H. ;
Umeda, M. ;
Kirita, T. ;
Kurita, H. ;
Shibuya, Y. ;
Komori, T. .
OSTEOPOROSIS INTERNATIONAL, 2017, 28 (08) :2465-2473
[10]   Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis Executive summary of recommendations from the American Dental Association Council on Scientific Affairs [J].
Hellstein, John W. ;
Adler, Robert A. ;
Edwards, Beatrice ;
Jacobsen, Peter L. ;
Kalmar, John R. ;
Koka, Sreenivas ;
Migliorati, Cesar A. ;
Ristic, Helen .
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2011, 142 (11) :1243-1251